Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Embecta Corp. (EMBC : NSDQ)

• Company Description    Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. Number of Employees: 1,850

• Price / Volume Information    Yesterday's Closing Price: $3.32 Daily Weekly Monthly 20 Day Moving Average: 3,695,044 shares Shares Outstanding: 59.33 (millions) Market Capitalization: $196.97 (millions) Beta: 1.09 52 Week High: $15.55 52 Week Low: $2.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -63.72% -65.49% 12 Week -68.32% -70.71% Year To Date -72.05% -74.31%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 Kimball Drive - Parsippany,NJ 07054 USA ph: 862-401-0000 fax: - investor.relations@embecta.com http://www.embecta.com

• General Corporate Information    Officers Devdatt Kurdikar - President and Chief Executive Officer David F. Melcher - Chairman of the Board and Director Jacob Elguicze - Senior Vice President; Chief Financial Officer Carrie L. Anderson - Director Claire Pomeroy - Director Peer Information Embecta Corp. (CHCR) Embecta Corp. (ESRX) Embecta Corp. (MYDP) Embecta Corp. (COR) Embecta Corp. (GBCS) Embecta Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 29082K105 SIC: 3841 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/14/26 Share - Related Items Shares Outstanding: 59.33 Most Recent Split Date: (:1) Beta: 1.09 Market Capitalization: $196.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 18.07% Current Fiscal Quarter EPS Consensus Estimate: $0.26 Indicated Annual Dividend: $0.60 Current Fiscal Year EPS Consensus Estimate: $1.62 Payout Ratio: 0.23 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.01 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/27/2026 - $0.15 Next EPS Report Date: 08/14/26

• Fundamental Ratios P/E Current FY Estimate: 2.06 Trailing 12 Months: 1.28 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 0.83 Price / Sales: 0.19 EPS Growth vs. Year Ago Period: -61.43% vs. Previous Quarter: -61.97% Sales Growth vs. Year Ago Period: -14.36% vs. Previous Quarter: -15.08% ROE 03/31/26 - -23.96 12/31/25 - -26.66 09/30/25 - -24.62 ROA 03/31/26 - 14.12 12/31/25 - 16.06 09/30/25 - 15.40 Current Ratio 03/31/26 - 2.46 12/31/25 - 2.64 09/30/25 - 2.41 Quick Ratio 03/31/26 - 1.68 12/31/25 - 1.87 09/30/25 - 1.73 Operating Margin 03/31/26 - 14.70 12/31/25 - 16.48 09/30/25 - 16.10 Net Margin 03/31/26 - 10.73 12/31/25 - 12.92 09/30/25 - 8.83 Pre-Tax Margin 03/31/26 - 16.27 12/31/25 - 18.14 09/30/25 - 12.62 Book Value 03/31/26 - -10.55 12/31/25 - -10.35 09/30/25 - -11.12 Inventory Turnover 03/31/26 - 2.14 12/31/25 - 2.21 09/30/25 - 2.28 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©